HCPCS Code Detail Logo

HCPCS Codes Similar to G0567

HCPCS Codes Similar to “G0567” Code.
Infectious agent detection by nucleic acid (dna or rna); hepatitis c, screening, amplified probe technique

U0003
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r
Code added date: 20200414
Code effective date: 20230512
U0005
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2
Code added date: 20210101
Code effective date: 20230512
G0476
Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test
Code added date: 20150709
Code effective date: 20150709
G0432
Infectious agent antibody detection by enzyme immunoassay (eia) technique, hiv-1 and/or hiv-2, screening
Code added date: 20091208
Code effective date: 20101001
G0433
Infectious agent antibody detection by enzyme-linked immunosorbent assay (elisa) technique, hiv-1 and/or hiv-2, screening
Code added date: 20091208
Code effective date: 20130101
G0435
Infectious agent antibody detection by rapid antibody test, hiv-1 and/or hiv-2, screening
Code added date: 20091208
Code effective date: 20101001
M1368
Prevention and treatment of infectious disorders including hepatitis c and hiv mips value pathway
Code added date: 20240101
Code effective date: 20240101
G8460
Clinician documented that patient is not an eligible candidate for quantitative rna testing at week 12; patient not receiving antiviral treatment for hepatitis c
Code added date: 20080101
Code effective date: 20170101
G9203
Rna testing for hepatitis c documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c
Code added date: 20140101
Code effective date: 20170101
G9204
Rna testing for hepatitis c was not documented as performed within 12 months prior to initiation of antiviral treatment for hepatitis c, reason not given
Code added date: 20140101
Code effective date: 20170101
G9209
Hepatitis c quantitative rna testing documented as performed between 4-12 weeks after the initiation of antiviral treatment
Code added date: 20140101
Code effective date: 20170101
G9210
Hepatitis c quantitative rna testing not performed between 4-12 weeks after the initiation of antiviral treatment for documented reason(s) (e.g., patients whose treatment was discontinued during the testing period prior to testing, other medical reasons, patient declined, other patient reasons)
Code added date: 20140101
Code effective date: 20170101
G9211
Hepatitis c quantitative rna testing was not documented as performed between 4-12 weeks after the initiation of antiviral treatment, reason not given
Code added date: 20140101
Code effective date: 20170101
G0545
Visit complexity inherent to hospital inpatient or observation care associated with a confirmed or suspected infectious disease by an infectious diseases specialist, including disease transmission risk assessment and mitigation, public health investigation, analysis, and testing, and complex antimicrobial therapy counseling and treatment (add-on code, list separately in addition to hospital inpatient or observation evaluation and management visit, initial, same day discharge, subsequent or discharge)
Code added date: 20250101
Code effective date: 20250101